Skip to content
10-K

Annual Report

Eastgate Biotech Corp

0001640334-18-000403

← back to feed
Filed
Mar 1, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Feb 28, 2018 934.31M sh
Cash And Equivalents FY 2016 · Dec 31, 2016 $0
Cash And Equivalents FY 2016 · Dec 31, 2015 $19.24K
Cash And Equivalents FY 2016 · Dec 31, 2014 $286.48K
Stockholders Equity FY 2016 · Dec 31, 2016 −$4.62M
Stockholders Equity FY 2016 · Dec 31, 2015 −$2.48M
Stockholders Equity FY 2016 · Dec 31, 2014 −$1.4M
Current Liabilities FY 2016 · Dec 31, 2016 $4.58M
Current Liabilities FY 2016 · Dec 31, 2015 $2.73M
Total Liabilities FY 2016 · Dec 31, 2016 $4.62M
Total Liabilities FY 2016 · Dec 31, 2015 $2.78M
Total Assets FY 2016 · Dec 31, 2016 $0
Total Assets FY 2016 · Dec 31, 2015 $297.92K
Sga Expense FY 2016 · Dec 31, 2016 $1.81M
Sga Expense FY 2016 · Dec 31, 2015 $2.54M
Rd Expense FY 2016 · Dec 31, 2016 $501.83K
Rd Expense FY 2016 · Dec 31, 2015 $1.12M
Net Income FY 2016 · Dec 31, 2016 −$2.98M
Net Income FY 2016 · Dec 31, 2015 −$4.28M
Operating Income FY 2016 · Dec 31, 2016 −$2.63M
Operating Income FY 2016 · Dec 31, 2015 −$4.17M
Current Assets FY 2016 · Dec 31, 2015 $113.52K
Gross Profit FY 2016 · Dec 31, 2015 $112.83K